Peter Niehoff

Genomewide Pharmacogenetics of Bisphosphonate-Induced Osteonecrosis of the Jaw: The Role of RBMS3

Breast cancer

The Evolving Role of Partial Breast Irradiation in Early-Stage Breast Cancer

Fracture healing: mechanisms and interventions

Expanding global access to radiotherapy

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer

Breast cancer

Enhanced bone regeneration with sequential delivery of basic fibroblast growth factor and sonic hedgehog

Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes

Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial

Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Pyroptosis: mechanisms and diseases

Quality Indicators for Breast Cancer: Revisiting Historical Evidence in the Context of Technology Changes

Past, present, and future of radiotherapy for the benefit of patients

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context

Prevention and Treatment of the Consequences of Head and Neck Radiotherapy

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

Oral Sequelae of Head and Neck Radiotherapy

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment

BMP-2 and bFGF in an irradiated bone model

Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)

Prophylaxe und Therapie akuter Strahlenfolgen an Haut und Schleimhaut

Long-term outcome following high dose rate brachytherapy and external in men with localized prostate cancer. Does elective irradiation of the pelvic lymphatic compromise the feasibility of local dose escalation?

73 HDR brachytherapy treatment for local recurrence after radical prostatectomy: First results and experiences